PTCA dilation catheters market seen reaching $2.68 billion by 2030

The PTCA dilation catheters market is forecast to grow from $2.09 billion in 2026 to $2.68 billion by 2030, driven by rising cardiovascular disease, more interventional procedures and broader hospital investment. North America led the market in 2025 as demand for minimally invasive cardiac treatment continued to expand.

Why it matters: - PTCA dilation catheters are used to open narrowed coronary arteries and restore blood flow during minimally invasive cardiac procedures. - Rising cardiovascular disease rates are expanding the patient pool for interventional cardiology tools. - The market’s projected growth points to continued demand for catheterization lab equipment, balloon technologies and procedural capacity.

What happened: - The Business Research Company released a 2026 market report on the global PTCA dilation catheters market. - The market was estimated at $1.95 billion in 2025 and is forecast to reach $2.09 billion in 2026. - The report projects the market will climb to $2.68 billion by 2030. - The forecast implies a 6.8% CAGR from 2025 to 2026 and a 6.4% CAGR from 2026 to 2030. - North America led the global market in 2025.

The details: - PTCA dilation catheters use a balloon at the tip of the catheter to widen blocked or narrowed coronary arteries. - The procedure improves circulation and helps reduce symptoms tied to coronary artery blockages. - Growth is tied to the rising prevalence of coronary artery disease, an aging population, advances in interventional cardiology, better diagnostic imaging and more hospital catheterization facilities. - The longer-term outlook is supported by more cardiovascular interventions, healthcare infrastructure investment in emerging markets, catheter material innovation, stronger clinical expertise and precision cardiology adoption. - Reported market trends include greater use of minimally invasive procedures, higher demand for non-compliant catheters, more durable balloon materials, expanded catheterization lab infrastructure and a focus on higher procedural success rates. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa in addition to North America. - The Business Research Company said its 2026 report package includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspot infographics, key technology analysis and updated graphics and tables. - The company offered a free sample report at Download the free sample. - The company also shared the full report at View the full market report.

Between the lines: - The forecast reflects a broader shift toward less invasive cardiovascular treatment and more precise device-driven care. - The American Heart Association projected in June 2024 that about 45 million U.S. adults could have some form of cardiovascular disease by 2050, up from 28 million in 2020. - The same projection cited increases in hypertension from 51.2% to 61.0% and obesity from 43.1% to 60.6%, reinforcing the pressure on the treatment market. - North America’s lead suggests mature healthcare systems still dominate current device adoption, while emerging markets may drive incremental growth.

What's next: - PTCA dilation catheters are expected to benefit from continued growth in cardiovascular interventions and hospital infrastructure spending. - Market expansion will likely depend on adoption of newer catheter materials, non-compliant balloon designs and precision cardiology workflows. - The Business Research Company positioned the market as one to watch through 2030 as global procedure volumes rise.

The bottom line: - PTCA dilation catheters are moving with a steady, procedure-driven market that could add more than $700 million in value by 2030.